AugustoC.OchoaMD

Allergy & Immunology • New Orleans, LA

Pediatric Asthma & Allergic Conditions

Professor, Pediatrics, LSU School of Medicine New Orleans

Join to view full profile

Dr. Ochoa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ochoa's full profile

Already have an account?

Office
200 Henry Clay Ave
New Orleans, LA 70118
Phone+1 504-412-1835

Education & Training

Louisiana State University School of MedicineFellowship, Allergy and Immunology, 2001 - 2003
Louisiana State University School of MedicineResidency, Pediatrics, 1997 - 1999
University De Antioquia, Fac De MedClass of 1982

Certifications & Licensure

LA State Medical License 2000 - 2025
MD State Medical License 2024 - 2025
American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
Completed
Phase 3
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Start of enrollment: 2010 Feb 15
Completed
Phase 3
Aspirin in Reducing Events in the Elderly Start of enrollment: 2010 Jan 01
Active, not recruiting
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Start of enrollment: 2012 Aug 08
Active, not recruiting
Phase 3
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29
Active, not recruiting
Phase 3
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Active, not recruiting
Phase 3
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy Start of enrollment: 2017 Apr 28
Active, not recruiting
Phase 3
S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer Start of enrollment: 2017 Feb 24
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Disparities in the use of screening breast magnetic resonance imaging persist in Louisiana after the Affordable Care Act: A question of access, policy, institutional s...
Brooke L Morrell, Mignonne B Morrell, Jane A Ball, Augusto C Ochoa, Victoria L Seewaldt
Cancer. 2023-03-15
4 citations
Association of Abdominal Visceral Adiposity and Total Fat Mass with Cancer Incidence and Mortality in White and Black Adults.
Peter T Katzmarzyk, Justin C Brown, Shengping Yang, Emily F Mire, Xiao-Cheng Wu
Cancer Epidemiology, Biomarkers & Prevention. 2022-08-02
8 citations
Association of Obesity and Diabetes With the Incidence of Breast Cancer in Louisiana.
Fokhrul M Hossain, Denise M Danos, Qiufan Fu, Xinnan Wang, Richard A Scribner
American Journal of Preventive Medicine. 2022-07-01

Press Mentions

LSU LCMC Health Cancer Center Experts Discuss Advances in Research and Goals for a Healthier LouisianaSeptember 24th, 2024
Real-World Data Collab Aims to Improve Diversity in Cancer Clinical TrialsSeptember 30th, 2022
NCI NCORP-Designated LSU Health New Orleans and ConcertAI Advance Multi-Year Collaboration Addressing Diversity in Clinical TrialsSeptember 27th, 2022
Join now to see all

Grant Support

Arginine Availability, Modulated By Mdsc, Regulates T Cell Function In CancerNational Cancer Institute2009–2012
Arginase Production In Cancer: Evading Immune ResponseNational Cancer Institute2004–2012
Core 5: AdministrativeNational Center For Research Resources2011
Core 2: ImmunologyNational Center For Research Resources2011
Mentoring Translational Researchers In LouisianaNational Center For Research Resources2005–2011
Lsuhsc Cobre: Core 5: Genomics CoreNational Center For Research Resources2010
TbnNational Center For Research Resources2009–2010
Lsuhsc Cobre: Core 2: Administrative CoreNational Center For Research Resources2006–2010
Lsuhsc Cobre: Core 7: Imaging CoreNational Center For Research Resources2005–2010
Lsuhsc Cobre: Core 1: Immunology &Cell AnalysisNational Center For Research Resources2005–2010
Lsuhsc Cobre: Core 5: Microarray &Sequencing CoreNational Center For Research Resources2009
To BE AnnouncedNational Center For Research Resources2007–2009
Arginine Regulates T Cell Signal Transduction &FunctionNational Cancer Institute2002–2007
Alterations In T-Cell Signal Transduction ProteinsNational Center For Research Resources2004
Immune Dysfunction And Immunotherapy Of Renal CancerNational Cancer Institute2001–2003
T Cell Signal Transduction To Monitor HPV VaccinesNational Cancer Institute2000–2001
Induction Of Anergy And Altered Signal TransductionNational Cancer Institute1999–2001
Long-Term LAK Cells--Effectors And In Vivo RelevanceNational Cancer Institute1988–1989